Answers are grounded in this paper and cite their sources.
OBJECTIVES: In the cancer therapy, the role of central venous access device has been increased because of factors; such as accessing to vein frequently, having long term therapy, using of sclerosan agents, giving much fluid. A chemoport is a thin, soft, plastic tube surgically implanted into a vein in chest or arm. Portacath doesn't have a huge size and it can generate numerous advantages. All the same, portacaths have risks such as infection, thrombosis, mechanical failure, pneumothorax, arterial injury. METHODS: A retrospective study was performed with analysis of records of 82 patients admitted to our clinics between December 2006 and November 2008 for permanent catheterisation via subclavian vein. RESULTS: The most frequent complication was occlusion of port (3.66%). Further complications were infection (2.43%), migration out of the blood vessel (1.22%), and catheter rupture (1.22%). CONCLUSION: As a result, made by people who experienced venous ports inserted, provided the opinion that a safe and comfortable method.
No takes yet. Share an insight, caveat, or question.
Süslü et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: